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Synthesis and Antimicrobial, Antiproliferative Evaluation of
Novel Quinolone and Conazole Analogues via Conventional
and Microwave Techniques
Şule Ceylan,[a] Yıldız Uygun Cebeci,*[b] Şengül Alpay Karaoğlu,[c] and Muhammed Altun[d]
1,2,4-Triazole-3-one (3), acquired from cinnamaldehyde was
converted to the corresponding carbox(thio)amides via several
steps (6a–c). Their reaction with sodium hydroxide gave the
1,2,4-triazole derivatives (7a–c). Compound 3 treatment with 2-
bromo-1-(4-chlorophenyl) ethanone or 2-chloro-1-(2,4-dichlor-
ophenyl)ethanone afforded the compounds 8a,b and by
reducing these compounds reduction products were obtained
(9a,b). The synthesis of (10a–e) was carried out by the reaction
compounds 9a,b with different benzyl chlorides. Then oxadia-
zole derivative (12) was obtained by ring closure from
hydrazide compound 5. Subsequently compounds 3, 7a–c, and
12 were treated with various amines in the presence of
formaldehyde to yield Mannich bases (11a–e, 14a–e, 13a,b).
Microwave-assisted and conventional techniques were utilized
for the syntheses. The structures of newly synthesized com-
pounds were illuminated by spectroscopic methods. Their
antimicrobial (MIC method), and anticancer activities (Abay’s
method) were examined. Results showed that most of the
compounds exhibited good antimicrobial activities. Especially
compounds 14a–e which is a mannich base showed very good
antitubercular activity against Mycobacterium smegmatis com-
pared with Streptomycin standard drug. Also compounds 8a
and 9b have been found to have strong antiproliferative effects
on the HeLa cervical cancer cells and also these compounds
did not have a cytotoxic effects on a normal cells.
Introduction
Cancer is the result of uncontrolled growth of cells a major
health concern and amongst the most important reasons for
death worldwide.[1–3] The World Health Organization’s cancer
agency warns that there will be 22 million new cases of cancer
every year within the next two decades.[4] Hence, cancer
treatment is the primary task of today’s medical research.[5]
Despite the invention of several chemotherapeutic agents, still
the treatment of cancer is a major challenge, because of multi-
drug resistance, toxicity, or poor bioavailability. The effective-
ness of many anticancer drugs is limited by acquired resistance
to drugs, side effects due to their toxicity to normal cells
because of their inability to differentiate between normal and
cancerous cells. In this context, there is a need to design and
synthesize new, effective, and less toxic anticancer agents
throwing a challenge to medicinal chemists all over the
World.[6,7]
Infectious diseases continue to be a leading threat to
human health, and the rapid development of bacterial
resistance to current antibiotic chemotherapies has rendered
lots of therapy weapons less effective.[8] It is anticipated that
antibiotic resistance is going to cause more than 10,000,000
deaths per year by the year 2050, posing a formidable
challenge for disease treatment as pathogens become resistant
to clinical drugs.[9] The World Health Organization has launched
a global action plan calling on all countries to take measures
towards drug-resistant microbes, and the discovery of effica-
cious and safer antimicrobials with new or multiple mecha-
nisms of action has been an urgent need to combat resistant
strains.[10,11]
Organic molecules bearing heterocyclic compounds have
received significant consideration in all fields of life comprising
medicinal, pharmaceutical, combinatorial, natural resources,
agriculture and dyes products.[3,12] Hybrid compounds are
molecules with two or more structural fields, which have
diverse dual activities and biological features. These substances
generally possess the capacity to get over medicine resistance,
develop pharmacokinetic structures, and abate toxicity.[13,14]
Triazoles are an important class of aromatic five-membered
heterocyclic compounds with a wide variety of biological
activities. They consist of two structural isomers: 1,2,3- and
1,2,4-triazole. Compounds based on 1,2,4-triazole scaffold show
diverse biological and pharmacological activities.[15–17] The
synthesized compounds having 1,2,4-triazole-3-thione skele-
tons have been reported to possess biological and pharmaco-
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logical activities such as anticonvulsant, urease inhibition,
antioxidant, analgesic. anti-parasitic, antiulcer, anticancer, anti-
HIV, anti-tuberculosis, antiamoebic, antigiardial, antiepileptic,
anti-inflammatory, antidepressant, and anxiolytic.[18–25]
Quinolones are widespread pharmacophores in anti-bacte-
rial substances. Fluoroquinolones are noted as one of the most
broadly used antibacterial agents for the cure of bacterial
illness. The cytotoxic activity of quinolone derivatives has
become the source of new anticancer agents, which might also
help to addres side toxicity and resistance.[26] Quinolones and
related derivatives are useful compounds with diverse pharma-
ceutical applications, and some have even reached markets for
the treatment of various ailments.[27] Thus, the hybridization of
quinolone with 1,2,4-triazole is inclined to present hopeful anti-
bacterial agents.[28–30]
Imidazoles and triazoles, as a group called conazoles, are
currently used worldwide as fungicides for grain, vegetable,
fruit, and flower production and as pharmaceuticals for the
treatment of human mycoses including vaginal mycoses in
pregnant women and thrush in infants.[31]
Recently, multicomponent reactions (MCRs) have received
considerable attention from synthetic organic and medicinal
chemists for the construction of complex molecules having
biological activity. When compared with conventional organic
reactions, MCRs have some superior properties including high
conversion rate, minimal reaction time, and structural complex-
ity. Thus, MCRs are also considered green chemical
processes.[32,33] Among these, the Mannich reaction, a one-pot
three-component condensation reaction, provides synthetically
and biologically important β-aminoalkylated compounds,
which are important intermediates for the construction of
various nitrogen-containing natural products and
pharmaceuticals.[34–36]
Microwave-assisted organic synthesis of various heterocy-
clic moieties is an effective and environment-friendly synthetic
approach and becoming an effective tool of the green
chemistry method. Microwave-assisted techniques were re-
ported to be more effective in perspective of the environment,
reaction time, high yields, ease of work-up, and isolation of
products. Moreover, solvents which are often expensive, toxic,
difficult to remove in the case of aprotic dipolar solvents with a
high boiling points, and are environmentally polluting agents,
are not necessary most of microwave-assisted synthesis.[37–40]
One of the main strategies for the discovery of new drugs is
combining two or more pharmacophoric moieties in a single
molecule to obtain the synergistic effect or to obtain antitumor
agents that have a novel mode of action. For this purpose, in
this study, various quinolone and conazole derivatives were
synthesized using conventional and microwave methods, and
antimicrobial and anticancer activities of these newly synthe-
sized compounds were determined using various methods.
Results
Chemistry
The primary target of this study was to develop antimicrobial
hybrid substances covering various pharmacophore structures.
Reactions of last and intermediate compounds were achieved
as pictorial in Scheme 1, Scheme 2, Scheme 3, and Scheme 4.
The synthesis was carried out by utilizing microwave-assisted
and conventional methods. The finishing of the synthesis was
observed via the thin-layer chromatography (TLC) process. All
product structures were based on the foundation of spectral
and physicochemical data.
Antimicrobial Activity
All new products were tested for their antimicrobial properties
utilizing the minimal inhibition concentration method (MIC)
and the outcomes for active molecules are illustrated in
Table 1. The antimicrobial activities of compounds (2-9) were
tested against 4 bacteria and 3 yeasts.
Among the synthesized compounds, compounds 3–9
displayed moderete activity in relation to testing microorgan-
isms while showing better activities on the M. smegmatis and E.
coli. That is compounds 7b and 8b have more effective for M.
smegmatis than the other molecules with the MIC values of
62.5 and 1.95 μg/mL respectively. M. smegmatis is one of an
acid-fast, aerobic-rapidly growing bacterial species in the genus
Mycobacterium and constitutes one of the characteristic tuber-
culosis agents causing death and morbidity. On the other
hand, compound 9a, an intermediate, showed excellent
activity on E. coli, a gram-negative bacterium, at 0.24 μg/mL
MIC value. Namely, 9a exhibited much better activity against E.
coli than ampicillin used as a standard drug. E. coli which is rod-
shaped, gram-negative enteric bacteria which lives in the
enteric systems of humans and animals and are found in aqua
and fecal substance.
Compounds 10a–e which are conazole derivatives exhib-
ited slight activity on the gram-positive and gram-negative
bacteria and yeasts. But compound 10c no antimicrobial
effects were found towards the test microorganisms.
Mannich bases 11a–e displayed good antibacterial activity
to test microorganisms. However, these compounds presented
not good antimicrobial effect against the yeast strains C.
albicans and S. cerevisiae. Only compound 11e, containing
phenyl piperazine, showed a moderate activity MIC value of
156 μg/mL on S. cerevisiae.
Oxadiazole compound, 12, obtained as a result of ring
closure, has low activity on all the microorganisms. But,
mannich bases 13a,b obtained from the reaction of the
oxadiazole compound with the quinolone showed strong
activities. Especially compound 13a exhibited the best activity
among all compounds synthesized against yeast strains with
78 μg/mL MIC value on S. cerevisiae. That is 13a has good
antifungal activity.
Among the synthesized compounds, 11a–e mannich bases
demonstrated the best and excellent activity against gram-
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<1 and 31.25 μg/mL, while showing no activity against yeast
strains. At the same time, these compounds showed very good
antitubercular activity against M. smegmatis compared with
Streptomycin standard drug.
No antimicrobial effects were found against the test micro-
organisms in the studied concentration ranges of the 4, 6a,b,
8a, and 10c compounds. Therefore, these results are not
included in the table.
Anticancer Activity
The antiproliferative activity potentials of the molecules were
examined by Abay’s[41] method against HeLa cells. Three
different doses of the samples showed different antiprolifer-
ative activity against the cells (Figure 1 and Figure 2). High Cell
Index (CI) values (red line) were obtained from the wells
without the molecules samples. Lower CI values were obtained
from the wells in which the molecules were added. Only the
medium (DMEM) was added to the final three wells. These
three wells were used to obtain a baseline. No impedance
change was observed in these wells containing only DMEM.
Therefore, the Cell Index (CI) values of these three wells did not
increase at all and straight continued to the end of the
experiment (green line) similarly.
CI values obtained from only DMEM and cell-added wells
were shown as the red line. The HeLa cells that continue to
develop without encountering any obstacles have caused the
CI to rise rapidly. This situation shows that the cells are
attached to gold-plated microelectrodes in the well ground
during the experiment and there is no proliferative negativity.
The more the cells attached to the electrodes on the plate
floor, the greater the impedance change. This results in an
increases in CI value. On the contrary, the decrease in CI value
means that the proliferation of the cells is suppressed or
inhibited.
The hard CI decline seen at the 2nd hour is due to the
change in the temperature of the e-Plate 96 taken from the
RTCA station in the incubator (95% CO2, 37 °C) to the sterile
cabinet and the sample addition. After the addition of the
molecule samples, the E-Plate 96 was inserted into the station
in the CO2 incubator again. The cells in the wells with no added
samples were rapidly increased the CI values (red line).
However, the proliferation of the cells in the wells the samples
were added was strongly suppressed by the samples’ mole-
cules. This situation resulted in low CI values.
Scheme 1. Reactions and conditions. i: hydrazine hydrate, reflux for 11 h; ii: cinnamaldeyhde, 115–120 °C, oil bath, 2 h; iii: absolute ethanol, Na, ethyl
bromoacetate, reflux for 8 h; iv: absolute ethanol, hydrazine hydrate, reflux for 15 h; v: phenyl isothiocyanate (for 6a), benzyl isocyanate (for 6b) or phenyl
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80 minutes after the addition of the cells to the wells, the e-
plate was removed from the station and taken to the sterile
cabinet. The samples were added to the wells at three different
concentrations (100, 50, and 10 μgmL  1). Each dose of the
samples were evaluated in triplicate. The antiproliferative effect
of the molecules against HeLa cells was monitored in real-time
every 10 minutes and followed for 48 hours. The mean CI
values from the wells were calculated automatically with the
xCelligence RTCA SP software and the standard deviations are
shown as vertical bars.
Scheme 2. Reactions and conditions. i: absolute ethanol, sodium ethoxide, 2-bromo-1-(4-chlorophenyl)ethanone (for 8a) or 2-chloro-1-(2,4-dichlorophenyl)
ethanone (for 8b) reflux for 24 h or MW irridation, 120 °C, 150 W for 6 min.; ii: absolute ethanol, sodium borohydride, reflux for 16 h or MW irridation, 125 °C,
150 W for 8 min.; iii: tetrahydrofuran, sodiumhydride, 2,4-dichlorobenzyl chloride (for 10a, 10d), or 2,6-dichlorobenzyl chloride (for 10b) or 4-chlorobenzyl
chloride (for 10c, 10e), MW irridation, 100 °C, 150 W for 17 min.; iv: HCl, formaldehyde, norfloxacin (for 11a), ciprofloxacin (for 11b), morpholine (for 11c),
thiomorpholine (for 11d), 4-phenylpiperazine (for 11e), MW irridation, 80 °C, 100 W for 5 min.
Scheme 3. Reactions and conditions. i: absolute ethanol, CS2, KOH, reflux for 24 h.; ii: HCl, formaldehyde, norfloxacin (for 13a) or ciprofloxacin (for 13b), MW
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Scheme 4. Reactions and conditions. i: HCl, formaldehyde, norfloxacin (for 14a, 14b) or ciprofloxacin (for 14c, 14d, 14e), MW irridation, 80 °C, 100 W for 5 min.
Table 1. Antimicrobial activity of the compounds (μg/mL).
Comp.
No.
Minimal Inhibition Concentration Values (μg/mL)
Ec Yp Pa Sa Ef Bc Ms Ca Sc
3 – – 500 – – – – 500 –
5 – – – – – – – 125 –
6c – – – – 250 – – – –
7a 125 – – – – – – – –
7b – – – – – – 62.5 – –
7c – – – – – – – 125 250
8b 62.5 – – 125 – 125 1.95 – –
9a 0.24 – 500 – – – – – –
9b 250 – – – – – – – –
10a – – – – 250 – – – –
10b – – – – – – – 625 –
10d – – – – – – 125 – –
10e – – – – – – – 625 –
11a <1 1.9 3.9 – 3.9 7.8 3.9 – –
11b 1.9 62.5 15.6 – 15.6 31.25 31.25 – –
11c – 62.5 – – – – 62.5 312.5 312.5
11d 62.5 – 625 – – – – 312.5 312.5
11e 15.6 – >1000 – – – – 312.5 156
12 – – 500 – – 500 – 250 –
13a <1 7.8 – 156 19 39 3.9 312.5 78
13b 31.25 <1 – 9.7 9.7 9.7 <1 312.5 312.5
14a <1 <1 <1 – <1 1.9 <1 – –
14b <1 <1 <1 – <1 <1 <1 – –
14c <1 <1 <1 – <1 1.9 <1 – –
14d <1 <1 1.9 – – 1.9 1.9 – –
14e <1 <1 3.9 – <1 1.9 <1 – –
Amp. 10 18 >128 35 10 15
Strep. 4
Flu. <8 <8
Ec: E. coli ATCC 35218, Yp: Y. pseudotuberculosis ATCC 911, Pa: P. aeruginosa ATCC 10145, Sa: S. aureus ATCC 25923, Ef: E. faecalis ATCC 29212, Bc: B. cereus
709 Roma, Ms: M. smegmatis ATCC607, Ca: C. albicans ATCC 60193, S. cerevisiae RSKK 251, Amp.: Ampicillin, Strep.: Streptomycin, Flu.: Fluconazole, (–): no
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Dose effect investigations are performed by considering
terms such as a dose-dependent effect, dose-dependent
reverse effect, hormesis, and inverse hormesis.[42–44] Antiprolifer-
ative effects of these molecules against HeLa cells are shown in
Figure 1 and Figure 2.
CI values obtained from wells with no cells increased
rapidly (red line). Different doses of DMSO were added to the
wells with HeLa cells and no DMSO-induced antiproliferative
activity was observed (Figure 3). The effect of all doses of 5FU
used as a positive control was strong, and CI values were very
close to each other. None of the lower doses of the molecules
didn’t show an antiproliferative effect (10 μgmL  1, turquoise
line). All of the low doses of the molecules produced the same
CI as the control group. Only the low dose of compound 8a
partially dissociated from the control group towards the end of
the experiment (after 35 hours). However, this situation cannot
be considered as a net antiproliferative effect. On the 5FU
graph (Figure 4) used as a positive control, it is seen that the
low dose (turquoise line) has a clearly different CI value from
the red-colored CI values (negative control).
Middle doses of 8a and 9b, molecules (50 μgmL  1, pink
line) showed strong antiproliferative activity. They maintained
Figure 1. Time-CI (Cell Index) plot showing the antiproliferative activity test results of compound 8a against HeLa cell line (the concentration unit is μg/mL).
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their antiproliferative effects throughout the experiment. High
doses of molecules have also been found to have high
antiproliferative activities. High doses of the 9b molecule
(100 μgmL  1, dark blue line) showed very strong antiprolifer-
ative activity. High doses of the 8a molecule also showed a
strong antiproliferative effect (100 μgmL  1, dark blue line) on
HeLa cells. The effects of high doses of the 9b molecules were
so potent that the resulting CI values were the same as the 0 CI
values (green line) obtained from wells with no added cells.
This strong effect continued throughout the experiment.
The dose-effect differences of these molecules were most
clearly seen in 8a and 9b. These effects of molecules with
strong antiproliferative effects are due to their structural forms.
The antiproliferative activity potentials of the molecules that
didn’t show any effect or have a weak effect against HeLa cells
should be examined against other cancer cell lines and their
effects should be investigated.
Discussion
Schiff base (3) was obtained from the reaction of 3-alkyl-4-
amino-4,5-dihydro-1H-1,2,4-triazole-5-one (2) compound with
cinnamaldehyde, which was obtained from the reaction of
ester ethoxycarbonylhydrazone (1) and hydrazine hydrate.[45]
Figure 3. Adding different doses of DMSO to HeLa cell wells (the concentration unit is μg/mL).
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The object was to combine the 1,2,4-triazole nucleus with the
cinnamaldehyde since it is known that more efficacious
antimicrobial substances can be discovered by adding two
biologically effective components together into a single
molecular structure.[46,47] Thereafter product (3) was trans-
formed to the corresponding hydrazide derivative (5) by the
creation of ester (4). With the introduction of hydrazide
function in the molecule, two signals appeared at 4.23
anda0.88 ppm as D2Oaexchangeable singlets at the
1H NMRa-
data of the molecule (5). With the introduction of the hydrazide
group in the compound, two signals emerged at 5.25 and
9.17 ppm as D2O exchangeable singlets at the
1H NMR data of
molecule.
Molecules (6a–c) were performed by the treatment of
molecule (5) with phenyl- (for 6a), or benzyl isothiocyanate (for
6b), or phenyl isocyanate (for 6c) in dichlomethanolic solution
in good yields, and molecule constructions were confirmed via
FT IR, 1H NMR, 13C NMR, mass data.
The intramolecular cyclization of products (6a-c) at basic
media afforded in the transformation of carbox(thio)amide
function alter to 5-oxo(mercapto)-1,2,4-triazole derivatives and
so molecules 7a–c were synthesized. These compounds were
characterized by the presence of a signal at 13.70 and
14.02 ppm in the 1H NMR data as a D2O exchangeable singlet
confirming the existence of a   SH function (7a,b) and
10.77 ppm–NH function (for 7c). The stretching band derived
from these groups appeared at 2929 and 2932 cm  1, and C=O
(for 7c) was observed at 1626 cm  1 at the FT  IR data of these
molecules (Scheme 1).
Alkylation of products 3, via 2-bromo-1-(4-chlorophenyl)-
ethanone or 2-chloro-1-(2,4-dichlorophenyl)-ethanone in
ethanol performed compound 8a,b. These reactions, which
took place in 1440 minutes in the conventional method, took
place in 6 minutes in the microwave irradiated method. Studies
related to microwave synthesis which supports organic syn-
thesis in a shorter time and higher efficiency are available in
the literature.[48–50] NH proton attached to the triazole group
disappeared for compound 3 at thea1H NMR spectra. New
aromatic peaks were resonated in the region 7.27–7.67 ppm. In
13C NMR data of molecules, the carbon atom (C=O) was
observed between 192.56 and 194.43 ppm for the newly added
carbonyl group.
Compounds 9a,b was obtained with the reduction of the
carbonyl structure of products 8a,b with sodium borohydride
utilizing both classical heating and MWairradiation. When we
compare the traditional and microwave method MW irradiation
reduced the reaction time froma960 min. to 8amin. and
increased the yields. Looking at compound numbers 9a,b, the
carbonyl group peak has evanesced at the 13C NMR data and
OH peak added between 5.41 and 6.44 ppm in the 1H NMR.
The spreading band obtained in this group (OH) appeared
between 3374 and 3251 cm  1, in the FT-IR data of molecules.
Reactions of molecules 10a–e were afforded reaction of
molecule 9a,b and benzyl chlorides, such as 2,4-dichloro-, 2,6-
dichloro- and 4-chlorobenzyl,chlorides in an ambiance with of
NaH via MW synthesis method at 80 °C and 100 W for 5 min. In
both FT-IR and 1H NMR data of the molecules, the peaks due to
the   OH group have disappeared. Other peaks approving
molecule structures were displayed at the concerned chemical
ranges in the 1H NMR and 13C NMR spectra. Moreover, [M+1]
ion signals were appeared at the concerned m/z ranges
auxiliary the offered structures of molecules 10a–e (Scheme 2).
Oxadiazole compound (12) was obtained as a result of ring
closure reaction of hydrazide compound (5) with CS2 in basic
media. The NH and NH2 peaks resulting from the hydrazide
compound disappeared in both the FT-IR and 1H NMR data of
the oxadiazole derivative compound. Instead of those peaks,
SH peaks were added at 14.66 ppm in 1H NMR and 2749 cm  1
in the FT-IR. In addition, synthesized molecules confirmed 13C
NMR and Mass spectral data and elemental analysis results
consistent with the assigned structures (Scheme 3).
Mannich reaction is a three-component condensation
reaction involving active hydrogen-containing compound,
formaldehyde and a secondary amine. The amino alkylation of
aromatic substrates by the Mannich reaction is of considerable
importance for the synthesis and modification of biologically
active compounds.[51] Mannich bases found numerous practical
applications in the field of medicinal chemistry, it could be
responsible for enhancing physicochemical properties.[52] Man-
nich bases linked 1,2,4-triazole derivatives as containing a
significant biological activity that has been reported in the
literature.[53,54] Furthermore, several Mannich bases of triazole
derivatives including piperazine, thiomorpholine, or morpho-
line moiety were synthesized as antimicrobial agents in our
laboratory.[55,56] Fluoroquinolones are known as the most
broadly utilized synthetic antimicrobial substances; privileged
with wide spectrum antibacterial property, relatively low
occurrence of toxic and adverse effects along with a perfect
safety profile.[45]
Considering these facts in this research, the aminoalkylation
of structures 3, 7a–c, and 12 with different amines, such as
norfloxacin (for 11a, 13a, 14a, 14b), ciprofloxacin (for 11b,
13b, 14c, 14d, 14e), morpholine (for 11c), thiomorpholine
(11d), and 4-phenylpiperazine (for 11e) in an ambiance with
formaldehyde was performed using the MW-assisted Mannich
synthesis reactions (Scheme 2, Scheme 3 and Scheme 4). No
signal symbolizing the presence of the NH band exists on the
1HNMR and FT-IR spectra of products (11a–e, 13a,b, 14a–e),
and in the 1H NMR and 13C NMR spectra of molecules extra
signals originated from amine moieties were observed at the
concerned chemical ranges. These molecules displayed mass
spectral datum records reasonable with their constructions.
The use of microwave (MW) irradiation method consequen-
ces in very influential and clean results with notable develop-
ments compared to classical processes. The process via MW
irradiation ensured the more helpful road with developed
synthesis yields and shorter synthesis times.[57] Green Chemistry
would like the high yield of synthetic processes, the use of less
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Conclusions
This study states the synthesis of novel compounds having
various bioactive units via microwave irritation and conven-
tional techniques. The microwave method provided a more
efficient way for the synthesis of desired compounds. Also, the
antibacterial and antiproliferative activity of the synthesized
molecules were determined. Among the synthesized com-
pounds, the best antimicrobial activities were found to show
compounds 14a–e which are Mannich bases. Especially these
compounds showed very good antitubercular activity against
M. smegmatis compared with Streptomycin standard drug. And
also they exhibited better activity against E. coli than ampicillin
used as a standard drug. Middle and high doses of compounds
8a and 9b were found to have strong anticancer activity on
the HeLa cervical cancer cells.
Supporting Information Summary
You will find the synthetic route, yields, melting points and
spectral data, and FT-IR, 1H NMR, 13C NMR and mass spectra in
the Supporting Information file of newly synthesized com-
pounds. And also you will see the antimicrobial and anticancer
activity determination methods.
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